Abbott India Overview

  • Year Founded
  • 1944

Year Founded

  • Status
  • Public

  • Employees
  • 3,749

Employees

  • Stock Symbol
  • 500488

Stock Symbol

  • Investments
  • 1

  • Share Price
  • $280.89
  • (As of Friday Closing)

Abbott India General Information

Description

Abbott India Ltd is a multinational pharmaceutical company in India engaged in the manufacture and sale of pharmaceutical products. It operates a manufacturing facility in Goa and also manufactures products through independent contract manufacturers. The company sells its products through independent distributors within India. It operates under the principal business segment viz. Pharmaceuticals. The revenue of the Company consists of sale of products through various distributions channel who further sell products in the market. Geographically, the majority of the company's revenue is generated in India.

Contact Information

Formerly Known As
Boots Pure Drug, Boots Pure Drug Company (India) Limited, Boots Pure Drug Company Limited, Knoll Pharmaceuticals Limited, The Boots Company (India)Limited
Ownership Status
Publicly Held
Financing Status
Corporation
Corporate Office
  • 16th Floor, Godrej BKC
  • Plot C-68, G Block, Bandra-Kurla Complex, Bandra (East)
  • Mumbai, Maharastra 400051
  • India
+91 022
Primary Industry
Diagnostic Equipment
Other Industries
Other Consumer Non-Durables
Stock Exchange
BOM
Vertical(s)
Corporate Office
  • 16th Floor, Godrej BKC
  • Plot C-68, G Block, Bandra-Kurla Complex, Bandra (East)
  • Mumbai, Maharastra 400051
  • India
+91 022

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Abbott India Stock Performance

As of 13-Nov-2026, Abbott India’s stock price is $280.89. Its current market cap is $5.97B with 21.2M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$280.89 $283.93 $260.48 - $343.23 $5.97B 21.2M 2.14K $8.39

Abbott India Financials Summary

As of 30-Sep-2026, Abbott India has a trailing 12-month revenue of $776M.

In Thousands,
USD
TTM 30-Sep-2026 FY 2026 31-Mar-2026 FY 2025 31-Mar-2025 FY 2024 31-Mar-2024
EV 5,791,728 5,583,824 7,407,085 6,637,524
Revenue 776,350 783,908 757,708 706,303
EBITDA 250,590 216,313 202,403 178,457
Net Income 178,265 175,640 167,276 145,100
Total Assets 616,849 689,110 691,765 622,769
Total Debt 16,067 18,228 22,992 9,980
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Abbott India Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Abbott India‘s full profile, request access.

Request a free trial

Abbott India Patents

Abbott India Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-902078-A Therapeutic agents Inactive 06-Jun-1972
CA-896520-A Ammonia absorbing products Inactive 28-Mar-1972
CA-894207-A Therapeutic compositions for topical application Inactive 29-Feb-1972
DE-2264159-A1 Alcoxylcarbamoyl and sulfonamidotriazols, method for their manufacture and their use Inactive 31-Dec-1971
CA-881565-A Preparation of phenylalkanoic acids Inactive 21-Sep-1971
To view Abbott India’s complete patent history, request access »

Abbott India Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Abbott India Acquisitions (1)

Abbott India’s most recent deal was a Merger/Acquisition with Solvay Pharma India. The deal was made on 24-Nov-2010.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Solvay Pharma India 24-Nov-2010 Merger/Acquisition Pharmaceuticals
To view Abbott India’s complete acquisitions history, request access »

Abbott India ESG

Risk Overview

Risk Rating

Updated November, 04, 2026

26.81 | Med Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

Management

Management is related to actions taken to manage ESG issues

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

of 13,585

Rank

Percentile

Pharmaceuticals

Industry

of 852

Rank

Percentile

Pharmaceuticals

Subindustry

of 354

Rank

Percentile

To view Abbott India’s complete esg history, request access »

Abbott India FAQs

  • When was Abbott India founded?

    Abbott India was founded in 1944.

  • Where is Abbott India headquartered?

    Abbott India is headquartered in Mumbai, India.

  • What is the size of Abbott India?

    Abbott India has 3,749 total employees.

  • What industry is Abbott India in?

    Abbott India’s primary industry is Diagnostic Equipment.

  • Is Abbott India a private or public company?

    Abbott India is a Public company.

  • What is Abbott India’s stock symbol?

    The ticker symbol for Abbott India is 500488.

  • What is the current stock price of Abbott India?

    As of 13-Nov-2026 the stock price of Abbott India is $280.89.

  • What is the current market cap of Abbott India?

    The current market capitalization of Abbott India is $5.97B.

  • What is Abbott India’s current revenue?

    The trailing twelve month revenue for Abbott India is $776M.

  • What is Abbott India’s annual earnings per share (EPS)?

    Abbott India’s EPS for 12 months was $8.39.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process